7/1/2025BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...

7/1/2025Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...

6/30/2025Pfizer China's Emblaveo Cleared by NMPA for Tough Gram‑Negative Infec...

6/30/2025China Medical System to Pursue Secondary Listing on Singapore Exchange

6/30/2025China's Pharma Market Faces Mixed Performance in Q1 2025 Amid Shifting...

6/30/2025China's Draft National Medical Security Law: Seven Key Highlights Sign...

6/28/2025I-Mab Unveils Encouraging Givastomig Results in First-Line Gastric Can...

6/28/2025Innovent Wins Landmark China Approval for Obesity Drug Challenging Nov...

6/28/2025China Raises Per Capita Public Health Funding to Support Seniors, Chil...

6/28/2025China Releases Draft Medical Security Law for Public Comment

6/28/2025Recent Official and Executive Moves

6/27/2025Mabwell Strikes Major $596M Deal with Calico to Advance Anti-Aging IL-...

6/27/2025Arbutus and Qilu End Partnership as Arbutus Regains Full Rights to Imd...

6/27/2025Fresh Antitrust Guidelines to Address Pharmaceutical Monopoly Issues i...

6/26/2025Immvira Advances Toward HKSE Listing with Focus on Oncolytic Virus The...

6/26/2025Vor Bio Secures ex-China Global Rights to RemeGen's Telitacicept

6/24/2025Aclaris Launches Phase 1a/1b Study of ATI-052

6/24/2025BrightGene Reports Strong Phase 2 Results for Dual Agonist BGM0504 and...

6/24/2025Bio-Thera Expands Latin America Biosimilar Reach with New Stein Agreem...

6/24/2025China Issues Guidelines to Promote TCM and Western Medicine Collaborat...

6/23/2025Harbour BioMed Enters Global Partnership with Otsuka to Advance BCMAxC...

6/23/2025China's Retail Pharmacy Market Hits CNY 941.1B in 2024 as Online Pharm...

6/20/2025CanSinoBIO Obtained NDA Approval for its 13-Valent Pneumococcal Polysa...

6/20/2025Lepu Begins MRG007 Trial in China, Licenses Global Rights to ArriVent

6/20/2025Simcere Gains Approval to Market Insomnia Drug Quviviq in China

6/20/2025MindRank's Oral GLP-1RA MDR-001 Achieves Promising Phase IIb Results i...

6/20/2025Recent Executive Moves

6/19/2025China's Biotech Boom Forces U.S. Pharma to Weigh Innovation Against Es...

6/19/2025Chinese Biopharma Firms Reroute Supply Chains and R\&D Amid Escalating...

6/18/2025EpimAb's HKEX IPO Application Accepted, Prospectus Now Published

Page:4/363 Total number of articles:10881: [First][<<] [2] [3] [4] [5] [6] [>>] [End]